This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
|Articles|December 2, 2012
- Pharmaceutical Technology-12-02-2012
- Volume 36
- Issue 12
Pharmaceutical Technology, December 2012 Issue (PDF)
Job Security - Annual Employment Survey Results Show Increased Confidence
Advertisement
Articles in this issue
almost 14 years ago
Tracking the Supply Chainalmost 14 years ago
Harmonizing Global Efforts Against Counterfeitsalmost 14 years ago
Harnessing the Power of Fingerprinting Technologiesalmost 14 years ago
Mice on a Missionalmost 14 years ago
When Disaster Strikes at Homealmost 14 years ago
Acquisitions Reshape the Bio/Pharm Services Industryalmost 14 years ago
Health Policy Challenges for Obama Administrationalmost 14 years ago
Job Securityalmost 14 years ago
Innovation in a Leading Disease Target: Alzheimer'sAdvertisement
Related to this article
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Advertisement
Advertisement